Author of “Understanding Terrorism” and “Understanding Homeland Security” discusses 9/11 anniversary, 20 years of the War on Terror, and future threats to the U.S.

Ahead of the 20-year anniversary of the September 11 attacks, Gus Martin reflects on lessons learned from the War on Terror and the War in Afghanistan, and the ever-changing landscape of extremism at home and abroad.  Martin is a professor…

World Trade Center Historian Reflects on 20th Anniversary of 9/11

Two decades before the Twin Towers fell on September 11, 2001 they soared above the New York City’s skyline. Today, the towers stand only in our memory, says Angus Gillespie, a professor of American Studies at Rutgers University-New Brunswick and author of “Twin Towers: The Life of New York City’s World Trade Center,” who will teach a course this fall honoring the nearly 3,000 Americans killed in the attack.

20th Anniversary of Sept. 11 Attacks: Rutgers Experts Available

Rutgers University–New Brunswick faculty experts are available to discuss repercussions from the Sept. 11 terrorist attacks 20 years ago in the United States and around the world.  John J. Farmer, Jr. Farmer, former senior counsel and team leader of the…

World Trade Center Responders with the Greatest Exposure to Toxic Dust Have a Higher Likelihood of Liver Disease

Mount Sinai researchers have found evidence for the first time that World Trade Center responders had a higher likelihood of developing liver disease if they arrived at the site right after the attacks as opposed to working at Ground Zero later in the rescue and recovery efforts. Their study links the increase in liver disease risk to the quantity of toxic dust the workers were exposed to, which was greatest immediately after the September 11, 2001, attacks.

Elevated Leukemia Incidence Is Found in World Trade Center Rescue and Recovery Workers

Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have an increased overall cancer incidence compared to the general population, particularly in thyroid cancer, prostate cancer, and, for the first time ever reported, leukemia, according to a Mount Sinai study published in JNCI Cancer Spectrum in January.